Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …

Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …

Background There has been debate about whether statin therapy is as effective in women
as men, especially for primary prevention. Methods Meta‐analyses were performed on data …

For several decades, the role of hormone-replacement therapy (HRT) has been debated.
Early observational data on HRT showed many benefits, including a reduction in coronary …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Background Whether statin therapy is as effective in women as in men is debated, especially
for primary prevention. We undertook a meta-analysis of statin trials in the Cholesterol …

The guidelines for the ESC/EAS Guidelines for the management of dyslipidaemias produced
by the task force for the management of dyslipidaemias of the European Society of …

This Review is intended to help clinicians, patients, and the public make informed decisions
about statin therapy for the prevention of heart attacks and strokes. It explains how the …

The totality of evidence indicates menopausal hormone replacement therapy (HRT) effects
are determined by timing of initiation according to age and/or time since menopause …

Women may expect to spend more than a third of their lives after menopause. Beginning in
the sixth decade, many chronic diseases will begin to emerge, which will affect both the …